Longboard Pharmaceuticals, Inc. (LBPH)
Dec 2, 2024 - LBPH was delisted (reason: acquired by Lundbeck)
59.98
0.00 (0.00%)
Inactive · Last trade price on Nov 29, 2024

Longboard Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Longboard Pharmaceuticals stock had an average target of $52.29, with a low estimate of $32 and a high estimate of $60.

Price Target: $52.29 (-12.82%)
Analyst Consensus: Buy
No price target forecast data available
TargetLowAverageMedianHigh
Price$32$52.29n/a$60
Change-46.65%-12.82%n/a+0.03%

Analyst Ratings

The average analyst rating for Longboard Pharmaceuticals stock from 8 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.27
from -2.39
EPS Next Year
-2.88
from -2.27
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------1.70M
EPS
-3.78-1.93-2.56-2.39-2.27-2.88-3.21
No. Analysts
----998

Revenue Forecast

Revenue202420252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202420252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS202420252026202720282029
High-2.18-2.63
Avg-2.27-2.88
Low-2.23-3.06

EPS Growth

EPS Growth202420252026202720282029
High--
Avg--
Low--